Atossa Therapeutics
ATOS
#10703
Rank
โ‚น2.35 B
Marketcap
โ‚น236.08
Share price
0.00%
Change (1 day)
166.03%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2026 (TTM): -โ‚น3.46 Billion

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -โ‚น3.36 Billion a decrease over its 2024 earnings that were of -โ‚น2.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น3.46 Billion3.16%
2025 -โ‚น3.36 Billion36.33%
2024 -โ‚น2.46 Billion-15.25%
2023 -โ‚น2.9 Billion11.62%
2022 -โ‚น2.6 Billion30.84%
2021 -โ‚น1.99 Billion15.58%
2020 -โ‚น1.72 Billion3.41%
2019 -โ‚น1.67 Billion51.16%
2018 -โ‚น1.1 Billion40.41%
2017 -โ‚น0.79 Billion27.54%
2016 -โ‚น0.62 Billion-47.49%
2015 -โ‚น1.17 Billion-17.25%
2014 -โ‚น1.42 Billion35.91%
2013 -โ‚น1.04 Billion112.3%
2012 -โ‚น0.49 Billion46.53%
2011 -โ‚น0.34 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.525 T-69,600.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น135.28 B-3,823.25%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น140.77 B-3,974.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚น4.01 B-210.53%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚น5.01 Billion 37.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚น0.76 Billion-79.21%๐Ÿ‡บ๐Ÿ‡ธ USA